The DSM Biotechnology Center team, with Hans Roubos and Joep Schmitz as the leading scientists, is involved in the Horizon2020 SHIKIFACTORY100 project, granted for €8 million by the EU.
The project is coordinated by biotech SME SilicoLife, in cooperation with some of the most relevant players in Europe, covering leading research institutions, SMEs and DSM as large industrial company.
The SHIKIFACTORY100 project aims towards the production of a universe of more than 100 high value compounds from the shikimate pathway, a hub in cell metabolism, through the development of an optimized chassis and the proposal and implementation of novel biosynthetic routes for the production of known and new to nature molecules.
Read the press release or learn more on the SHIKIFACTORY100 project